Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
11.40
-0.02 (-0.18%)
At close: Aug 1, 2025, 4:00 PM
11.95
+0.55 (4.82%)
After-hours: Aug 1, 2025, 5:07 PM EDT
Model N Market Cap
Cogent Biosciences has a market cap or net worth of $1.59 billion as of August 1, 2025. Its market cap has increased by 61.95% in one year.
Market Cap
1.59B
Enterprise Value
1.36B
1-Year Change
61.95%
Ranking
Category
Stock Price
$11.40
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $1.59B, an increase of 1,179.61%. That is a compound annual growth rate of 65.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.59B | 84.56% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |